A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 6 Months in Adult Subjects
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Aclaris Therapeutics Inc.
Start Date
January 24, 2018
End Date
January 31, 2021
Administered By
Dermatology
Awarded By
Aclaris Therapeutics Inc.
Start Date
January 24, 2018
End Date
January 31, 2021